Delayed antibiotic prescribing for respiratory tract infections: protocol of an individual patient data meta-analysis.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
21 01 2019
Historique:
entrez: 24 1 2019
pubmed: 24 1 2019
medline: 20 2 2020
Statut: epublish

Résumé

Delayed prescribing can be a useful strategy to reduce antibiotic prescribing, but it is not clear for whom delayed prescribing might be effective. This protocol outlines an individual patient data (IPD) meta-analysis of randomised controlled trials (RCTs) and observational cohort studies to explore the overall effect of delayed prescribing and identify key patient characteristics that are associated with efficacy of delayed prescribing. A systematic search of the databases Cochrane Central Register of Controlled Trials, Ovid MEDLINE, Ovid Embase, EBSCO CINAHL Plus and Web of Science was conducted to identify relevant studies from inception to October 2017. Outcomes of interest include duration of illness, severity of illness, complication, reconsultation and patient satisfaction. Study authors of eligible papers will be contacted and invited to contribute raw IPD data. IPD data will be checked against published data, harmonised and aggregated to create one large IPD database. Multilevel regression will be performed to explore interaction effects between treatment allocation and patient characteristics. The economic evaluation will be conducted based on IPD from the combined trial and observational studies to estimate the differences in costs and effectiveness for delayed prescribing compared with normal practice. A decision model will be developed to assess potential savings and cost-effectiveness in terms of reduced antibiotic usage of delayed prescribing and quality-adjusted life years. Ethical approval was obtained from the University of Southampton Faculty of Medicine Research Ethics Committee (Reference number: 30068). Findings of this study will be published in peer-reviewed academic journals as well as General Practice trade journals and will be presented at national and international conferences. The results will have important public health implications, shaping the way in which antibiotics are prescribed in the future and to whom delayed prescriptions are issued. CRD42018079400.

Identifiants

pubmed: 30670532
pii: bmjopen-2018-026925
doi: 10.1136/bmjopen-2018-026925
pmc: PMC6347865
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e026925

Subventions

Organisme : Department of Health
ID : CDF-2009-02-10
Pays : United Kingdom
Organisme : Department of Health
ID : PB-PG-0416-20005
Pays : United Kingdom

Informations de copyright

© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

BMJ. 2013 Mar 11;346:f1493
pubmed: 23479660
BMJ. 2005 Aug 6;331(7512):301-2
pubmed: 16081428
BMJ. 2013 Oct 10;347:f5806
pubmed: 24114306
BMJ. 2015 Jan 02;350:g7647
pubmed: 25555855
Cochrane Database Syst Rev. 2013 Jun 04;(6):CD000247
pubmed: 23733381
Cochrane Database Syst Rev. 2013 Apr 30;(4):CD004417
pubmed: 23633320
Syst Rev. 2015 Jul 23;4:98
pubmed: 26202162
Lancet Infect Dis. 2014 Mar;14(3):213-9
pubmed: 24440616
Cochrane Database Syst Rev. 2016 Sep 06;9:MR000007
pubmed: 27595791
BMJ Open. 2016 Nov 18;6(11):e011882
pubmed: 27864242
BMJ. 2010 Feb 05;340:c221
pubmed: 20139215
J Clin Epidemiol. 2011 Apr;64(4):383-94
pubmed: 21195583
Stat Med. 1998 Oct 15;17(19):2265-81
pubmed: 9802183
Br J Gen Pract. 2011 Sep;61(590):e579-89
pubmed: 22152745
BMJ Open Respir Res. 2015 May 06;2(1):e000086
pubmed: 25973210
PLoS One. 2012;7(10):e46042
pubmed: 23056232
Br J Gen Pract. 2016 Sep;66(650):e633-9
pubmed: 27402969
BMJ. 2016 Oct 12;355:i4919
pubmed: 27733354
Cochrane Database Syst Rev. 2013 Nov 05;(11):CD000023
pubmed: 24190439
J Clin Epidemiol. 2002 Jan;55(1):86-94
pubmed: 11781126
Cochrane Database Syst Rev. 2017 Sep 07;9:CD004417
pubmed: 28881007
BMJ. 2010 May 18;340:c2096
pubmed: 20483949
J Clin Epidemiol. 2007 May;60(5):431-9
pubmed: 17419953
Stat Med. 2002 Feb 15;21(3):371-87
pubmed: 11813224
Ann Fam Med. 2016 Jul;14(4):325-36
pubmed: 27401420
Lancet Respir Med. 2016 Nov;4(11):902-910
pubmed: 27594440

Auteurs

Beth Stuart (B)

Academic Unit of Primary Care and Population Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.

Hilda Hounkpatin (H)

Academic Unit of Primary Care and Population Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.

Taeko Becque (T)

Academic Unit of Primary Care and Population Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.

Guiqing Yao (G)

Biostatistics Research Group, Department of Health Sciences, College of Life Sciences, University of Leicester, Leiceister, UK.

Shihua Zhu (S)

Academic Unit of Primary Care and Population Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.

Pablo Alonso-Coello (P)

Iberoamerican Cochrane Centre, Department of Clinical Epidemiology and Public Health, Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spain.

Attila Altiner (A)

Office for Educational Affairs, Department of General Medicine, University of Rostock, Rostock, Germany.

Bruce Arroll (B)

Department of General Practice and Primary Health Care, University of Auckland, Auckland, New Zealand.

Dankmar Böhning (D)

Southampton Statistical Sciences Research Institute, University of Southampton, Southampton, UK.

Jennifer Bostock (J)

Divison of Health and Social Care Research, King's College London, London, UK.

Heiner C C Bucher (HCC)

Basel Institute for Clinical Epidemiology and Biostatistics (CEB), University Hospital Basel and University of Basel, Basel, Switzerland.

Mariam de la Poza (M)

Institut Català de la Salut, CAP Doctor Carles Ribas, Barcelona, Spain.

Nick A Francis (NA)

Division of Population Medicine, School of Medicine, Cardiff University, Cardiff, UK.

David Gillespie (D)

Centre for Trials Research, College of Biomedical & Life Sciences, Cardiff University, Cardiff, UK.

Alastair D Hay (AD)

Centre for Academic Primary Care, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.

Timothy Kenealy (T)

Department of General Practice and Primary Health Care, University of Auckland, Auckland, New Zealand.

Christin Löffler (C)

Institute of General Practice, Rostock University Medical Center, Rostock, Germany.

Gemma Mas-Dalmau (G)

Knowledge and Research Management Unit, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.

Laura Muñoz (L)

Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS), Barcelona, Spain.

Kirsty Samuel (K)

ASPIRE PPI Panel, Leeds, Institute for Health Sciences, University of Leeds, Leeds, UK.

Michael Moore (M)

Academic Unit of Primary Care and Population Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.

Paul Little (P)

Academic Unit of Primary Care and Population Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH